BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15036676)

  • 1. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR.
    Retz M; Lehmann J; Szysnik C; Zwank S; Venzke T; Röder C; Kalthoff H; Basbaum C; Stöckle M
    Eur Urol; 2004 Mar; 45(3):314-9. PubMed ID: 15036676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II.
    Kurahashi T; Hara I; Oka N; Kamidono S; Eto H; Miyake H
    Clin Cancer Res; 2005 May; 11(10):3773-7. PubMed ID: 15897575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
    Copp HL; Chin JL; Conaway M; Theodorescu D
    Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
    Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
    Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes].
    Autenrieth M; Nawroth R; Semmlack S; Gschwend JE; Retz M
    Urologe A; 2008 Sep; 47(9):1157-61. PubMed ID: 18696039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder.
    Seraj MJ; Thomas AR; Chin JL; Theodorescu D
    Clin Cancer Res; 2001 Jun; 7(6):1516-22. PubMed ID: 11410485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.
    Okegawa T; Kinjo M; Horie S; Nutahara K; Higashihara E
    Urology; 2003 Jul; 62(1):182-6. PubMed ID: 12837463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
    Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
    Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.
    Schostak M; Krause H; Miller K; Schrader M; Kempkensteffen C; Kollermann J
    BJU Int; 2007 Jun; 99(6):1409-14. PubMed ID: 17428244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity.
    Maeda J; Inoue M; Okumura M; Ohta M; Minami M; Shiono H; Shintani Y; Matsuda H; Matsuura N
    Lung Cancer; 2006 May; 52(2):235-40. PubMed ID: 16510209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.
    Ramírez-Backhaus M; Fernández-Serra A; Rubio-Briones J; Cruz Garcia P; Calatrava A; Garcia Casado Z; Casanova Salas I; Rubio L; Solsona E; López-Guerrero JA
    Actas Urol Esp; 2015 Oct; 39(8):473-81. PubMed ID: 25920992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation.
    Goldsmith B; Baumann BC; He J; Tucker K; Bekelman J; Deville C; Vapiwala N; Vaughn D; Keefe SM; Guzzo T; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):603-10. PubMed ID: 24411628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of disseminated tumor cells in mediastinoscopic lymph node biopsies and lymphadenectomy specimens of patients with NSCLC by quantitative RT-PCR.
    Wang XT; Sienel W; Eggeling S; Ludwig C; Stoelben E; Mueller J; Klein CA; Passlick B
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):26-32. PubMed ID: 15939599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
    Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
    Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.
    Shariat SF; Kattan MW; Erdamar S; Nguyen C; Scardino PT; Spencer DM; Wheeler TM; Slawin KM
    J Clin Oncol; 2003 Apr; 21(7):1223-31. PubMed ID: 12663708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20.
    Wu X; Kakehi Y; Zeng Y; Taoka R; Tsunemori H; Inui M
    J Urol; 2005 Dec; 174(6):2138-42, discussion 2142-3. PubMed ID: 16280744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study for detecting micrometastases of lymph nodes in patients with lung cancer].
    Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Tong XY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):19-21. PubMed ID: 18346373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.